Fadia T. Shaya PhD, MPH, is Associate Professor, in Outcomes Research at the University of Maryland School of Pharmacy, and in Epidemiology and Preventive Medicine at the University of Maryland School of Medicine. She is also Associate Director for the Center on Drugs and Public Policy in the Department of Pharmaceutical Health Services Research. Prior to that, she worked in health care consulting in Washington DC and at the Johns Hopkins Bayview Medical Center; and at the Health Planning Commission in Paris, France.

Dr. Shaya has built research capacity to support all stages of drug development, from pre-clinical trials to post-marketing surveillance. She has experience in developing clinical, economic, decision analysis and budget impact models. She works with state, commercial and Medicare Part D plans, to guide drug formulary management, specifically relating to cardiovascular disease and COPD. Her portfolio of extra-mural research is supported by federal, commercial and foundation grants and contracts. A member of the Pharmacy and Therapeutics committee at CareFirst BlueCross BlueShield, she also serves on the Editorial Advisory Boards of the Journal of Medical Economics, the Journal of Managed Care Pharmacy, Expert Review in Pharmacoeconomics and Outcomes Research, and P&T. She is a reviewer for and has published in peer-reviewed journals, including Circulation, The Lancet, Health Affairs and Archives of Internal Medicine. Her current research focuses on comparative effectiveness, survival analysis, propensity scores modeling and applications to formulary decision-making. She regularly speaks at national and international scientific and policy meetings.

Dr. Shaya has served as the Chair of the State of Maryland Governor’s Advisory Council on Hepatitis C and Diseases of the Liver, and heads the MVP (Men’s Cardiovascular Health) Program and is the Co-PI of a large grant from the National Heart, Lung, and Blood Institute, to develop and implement a research partnership program with University of Maryland and Bon Secours Baltimore Health System. She has a large grant on the comparative effectiveness of treatments for liver cancer. In large part, her translational medicine work is based on public-private partnerships and community engagement initiatives.

Dr. Shaya obtained her PhD from the Johns Hopkins Bloomberg School of Public Health, her health economics degree from the Sorbonne University Paris-IX Dauphine and her MPH from the American University of Beirut.